Cargando…
Determining the survival benefit of postoperative radiotherapy in patients with pT1-3N1M0 rectal cancer undergoing total mesorectal excision: a retrospective analysis
BACKGROUND: The National Comprehensive Cancer Network guidelines recommend routine postoperative adjuvant radiotherapy and chemotherapy for patients with stage III rectal cancer who do not receive neoadjuvant therapy before surgery. The present study aimed to evaluate the value of postoperative radi...
Autores principales: | Chen, Jin-hu, Ye, Qing, Huang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037866/ https://www.ncbi.nlm.nih.gov/pubmed/36959560 http://dx.doi.org/10.1186/s12876-023-02697-4 |
Ejemplares similares
-
In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer
por: Wu, Jun-xin, et al.
Publicado: (2014) -
Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk
por: Lai, I-Li, et al.
Publicado: (2019) -
Total mesorectal excision for the treatment of rectal cancer
por: Zedan, Ali, et al.
Publicado: (2015) -
Robotic total mesorectal excision for the treatment of rectal cancer
por: Baik, Seung Hyuk, et al.
Publicado: (2007) -
Update on Robotic Total Mesorectal Excision for Rectal Cancer
por: Giuratrabocchetta, Simona, et al.
Publicado: (2021)